Valmet changes its financial reporting structure aligned with new strategy and provides comparative segment information for 2024 and January-March 2025

Valmet changes its financial reporting structure aligned with new strategy and
provides comparative segment information for 2024 and January-March 2025

Valmet Oyj's stock exchange release onJune 4, 2025 at 8:30 p.m. EEST

Valmet changes its financial reporting structure to reflect its new strategy,
which was published today, and the new operating model announced on March 31,
2025. The new operating model and reporting structure will take effect on July
1, 2025.

In the new financial reporting structure, Valmet consists of two reportable
segments: Biomaterial Solutions and Services, and Process Performance Solutions.

Biomaterial Solutions and Services segment provides technology solutions and
services throughout the lifecycle for its customers who operate mainly in pulp,
paper and energy industries.

Process Performance Solutions segment delivers flow control technologies as well
as automation solutions ranging from single measurements to mill- or plant-wide
process automation systems, along with the associated services. It has a
diversified portfolio of customer industries globally.

The two segments are comprised of business areas as follows:

  · Biomaterial Solutions and Services segment consists of three business areas:
    · Pulp, Energy and Circularity
    · Packaging and Paper
    · Tissue

  · Process Performance Solutions segment consists of two business areas:
    · Flow Control
    · Automation Solutions

The business areas Pulp, Energy and Circularity; Packaging and Paper; and Tissue
combine Valmet's technology and service businesses for their respective customer
industries. Each business area integrates technology deliveries and lifecycle
services to strengthen customer proximity, lifecycle focus, and value creation
with industry-specific offerings.

The Flow Control business area corresponds to the former Flow Control business
line. The Automation Solutions business area was previously called Automation
Systems business line.

For both reportable segments, Valmet will report orders received, net sales and
profitability (EBITA and comparable EBITA), as well as amortization and items
affecting comparability. Valmet will also report services orders received and
net sales for the Biomaterial Solutions and Services segment to maintain
visibility to this strategically important part of the business.

For each business area, Valmet will report orders received, net sales and
personnel.

Valmet will continue to report orders received, net sales and personnel for the
five geographical areas: North America, Latin America (previously South
America), EMEA, China and Asia-Pacific.

The new reporting structure is aligned with the way Valmet management follows
the operational performance of Valmet's businesses.

Valmet will change its financial reporting structure to correspond to the new
operating model in its January-September 2025 Interim Review. To provide a basis
for comparison, the following tables show financial information with the new
reporting structure on an unaudited basis for all four quarters and full year
2024, as well as first quarter of 2025. As additional information Valmet plans
to publish the corresponding financial information for the first six months of
2025 and for the second quarter 2025 in its Half Year Financial Review 2025.

Quarterly information

Orders received,  Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024   Q1/2025
EUR million
Biomaterial       722      930      719      2 020    4 392  926
Solutions and
Services
  Pulp, Energy    259      367      321      1 336    2 283  465
and Circularity
  Packaging and   298      402      317      412      1 428  340
Paper
  Tissue          166      162      81       272      681    121
  Of which        527      497      412      479      1 915  568
service
Process           328      352      322      443      1 446  406
Performance
Solutions
  Flow Control    194      195      188      185      763    215
  Automation      134      157      133      258      683    191
Solutions
Total             1 050    1 283    1 041    2 463    5 837  1 332

Net sales, EUR   Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024   Q1/2025
million
Biomaterial      903      973      941      1 104    3 922  846
Solutions and
Services
  Pulp, Energy   367      386      380      442      1 574  339
and Circularity
  Packaging and  412      443      417      474      1 746  387
Paper
  Tissue         124      144      145      189      602    119
  Of which       406      473      453      567      1 900  433
service
Process          309      351      354      424      1 437  339
Performance
Solutions
  Flow Control   188      201      196      206      791    192
  Automation     121      150      158      217      646    147
Solutions
Total            1 212    1 324    1 295    1 528    5 359  1 184

Comparable EBITA,  Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024  Q1/2025
EUR million
Biomaterial        80       95       101      128      403   82
Solutions and
Services
Process            51       58       65       81       255   55
Performance
Solutions
Other              -11      -12      -10      -17      -49   -16
Total              121      141      156      192      609   121

Comparable EBITA,  Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024   Q1/2025
% of net sales
Biomaterial        8.9%     9.8%     10.7%    11.6%    10.3%  9.7%
Solutions and
Services
Process            16.5%    16.5%    18.3%    19.1%    17.7%  16.2%
Performance
Solutions
Total              10.0%    10.6%    12.0%    12.6%    11.4%  10.2%

EBITA, EUR     Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024  Q1/2025
million
Biomaterial    77       87       84       116      364   80
Solutions and
Services
Process        50       58       64       76       248   54
Performance
Solutions
Other          -14      -13      -10      -19      -56   -21
Total          114      132      138      173      557   113

EBITA, % of net  Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024   Q1/2025
sales
Biomaterial      8.6%     9.0%     8.9%     10.5%    9.3%   9.5%
Solutions and
Services
Process          16.2%    16.4%    18.2%    17.9%    17.2%  16.0%
Performance
Solutions
Total            9.4%     9.9%     10.7%    11.3%    10.4%  9.6%

Items affecting  Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024  Q1/2025
comparability,
EUR million
Biomaterial      -3       -8       -17      -12      -39   -2
Solutions and
Services
Process          -1       0        0        -5       -7    -1
Performance
Solutions
Other            -3       -1       0        -3       -7    -5
Total            -7       -9       -17      -19      -53   -8

Amortization, EUR  Q1/2024  Q2/2024  Q3/2024  Q4/2024  2024  Q1/2025
million
Biomaterial        -11      -11      -11      -5       -36   -6
Solutions and
Services
Process            -12      -14      -14      -14      -54   -14
Performance
Solutions
Other              -4       -4       -4       -5       -18   -5
Total              -27      -29      -29      -23      -108  -24

Year-to-date information

Orders received,  Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024   Q1/2025
EUR million
Biomaterial       722      1 653       2 372       4 392  926
Solutions and
Services
  Pulp, Energy    259      625         946         2 283  465
and Circularity
  Packaging and   298      700         1 016       1 428  340
Paper
  Tissue          166      328         409         681    121
  Of which        527      1 024       1 436       1 915  568
service
Process           328      681         1 002       1 446  406
Performance
Solutions
  Flow Control    194      389         578         763    215
  Automation      134      291         425         683    191
Solutions
Total             1 050    2 333       3 374       5 837  1 332

Net sales, EUR   Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024   Q1/2025
million
Biomaterial      903      1 877       2 818       3 922  846
Solutions and
Services
  Pulp, Energy   367      753         1 132       1 574  339
and Circularity
  Packaging and  412      856         1 272       1 746  387
Paper
  Tissue         124      269         413         602    119
  Of which       406      880         1 333       1 900  433
service
Process          309      659         1 013       1 437  339
Performance
Solutions
  Flow Control   188      389         585         791    192
  Automation     121      271         429         646    147
Solutions
Total            1 212    2 536       3 831       5 359  1 184

Comparable EBITA,  Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024  Q1/2025
EUR million
Biomaterial        80       175         276         403   82
Solutions and
Services
Process            51       109         174         255   55
Performance
Solutions
Other              -11      -23         -32         -49   -16
Total              121      262         417         609   121

Comparable EBITA,  Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024   Q1/2025
% of net sales
Biomaterial        8.9%     9.3%        9.8%        10.3%  9.7%
Solutions and
Services
Process            16.5%    16.5%       17.1%       17.7%  16.2%
Performance
Solutions
Total              10.0%    10.3%       10.9%       11.4%  10.2%

EBITA, EUR     Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024  Q1/2025
million
Biomaterial    77       165         248         364   80
Solutions and
Services
Process        50       107         172         248   54
Performance
Solutions
Other          -14      -27         -36         -56   -21
Total          114      245         384         557   113

EBITA, % of net  Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024   Q1/2025
sales
Biomaterial      8.6%     8.8%        8.8%        9.3%   9.5%
Solutions and
Services
Process          16.2%    16.3%       17.0%       17.2%  16.0%
Performance
Solutions
Total            9.4%     9.7%        10.0%       10.4%  9.6%

Items affecting  Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024  Q1/2025
comparability,
EUR million
Biomaterial      -3       -11         -28         -39   -2
Solutions and
Services
Process          -1       -1          -2          -7    -1
Performance
Solutions
Other            -3       -4          -4          -7    -5
Total            -7       -16         -33         -53   -8

Amortization, EUR  Q1/2024  Q1-Q2/2024  Q1-Q3/2024  2024  Q1/2025
million
Biomaterial        -11      -21         -32         -36   -6
Solutions and
Services
Process            -12      -26         -40         -54   -14
Performance
Solutions
Other              -4       -9          -13         -18   -5
Total              -27      -56         -85         -108  -24

Further information, please contact:

Pekka Rouhiainen, VP, Investor Relations, Valmet, tel. +358 10 672 0020

VALMET

Katri Hokkanen

CFO

Pekka Rouhiainen

VP, Investor Relations

DISTRIBUTION:

Nasdaq Helsinki

Major media

www.valmet.com

Valmet has a global customer base across various process industries. We are a
leading global developer and supplier of process technologies, automation, and
services for the pulp, paper, and energy industries. With our automation and
flow control solutions, we serve an even wider base of process industries. Our
more than 19,000 professionals around the world work close to our customers and
are committed to moving our customers' performance forward - every day.

The company has more than 225 years of industrial history and a strong track
record in continuous improvement, sustainability, and renewal. Valmet's net
sales in 2024 were approximately EUR 5.4 billion.

Valmet's shares are listed on the Nasdaq Helsinki, and the head office is in
Espoo, Finland.

Follow us on valmet.com (https://www.valmet.com) |
X (https://x.com/valmetglobal) | X (IR) (https://x.com/ValmetIR) |
LinkedIn (https://www.linkedin.com/company/valmet/) |
Facebook (https://www.facebook.com/valmetcorporation) |
YouTube (https://www.youtube.com/c/Valmet/featured) |
Instagram (https://www.instagram.com/valmetglobal) |

Processing of personal data (https://www.valmet.com/content_folder/processing-of
-personal-data/)